ESTHER DIGIACOMO: Open Payments
NPI 1295972180 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 25 payments from 13 companies in 2025. Trend: 2023 $430 · 2024 $996 · 2025 $857
Food & beverage: $857
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $340 |
| Boston Scientific Corporation | 5 | $87 |
| CSL Behring | 3 | $81 |
| Alexion Pharmaceuticals, Inc. | 2 | $57 |
| UCB, Inc. | 2 | $48 |
| Averitas Pharma Inc. | 2 | $48 |
| MML US, Inc. | 1 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| ACADIA Pharmaceuticals Inc | 1 | $29 |
| SK Life Science, Inc. | 1 | $27 |
Products named: PROCLAIM, Hizentra, General - Pain Management, ULTOMIRIS, Nayzilam, QUTENZA, ReActiv8, HYQVIA.
Industry payments across PA — which companies pay providers there.
